SynthesisCancer chemotherapy and pharmacology2022

Correlation between immune-related adverse events and the efficacy of PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer: systematic review and meta-analysis.

Qian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.